TRxADE HEALTH (NASDAQ:MEDS) Trading Down 0.6% – What’s Next?

TRxADE HEALTH, Inc. (NASDAQ:MEDS)’s share price dropped 0.6% during trading on Monday . The stock traded as low as $6.99 and last traded at $6.99. Approximately 6,486 shares traded hands during mid-day trading, a decline of 97% from the average daily volume of 207,831 shares. The stock had previously closed at $7.03.

TRxADE HEALTH Trading Down 1.6 %

The firm has a fifty day moving average price of $7.42 and a 200 day moving average price of $8.75.

TRxADE HEALTH (NASDAQ:MEDS) last released its quarterly earnings data on Friday, August 9th. The company reported ($1.04) earnings per share (EPS) for the quarter. TRxADE HEALTH had a negative net margin of 149.81% and a negative return on equity of 196.79%. The business had revenue of $0.02 million during the quarter.

Institutional Investors Weigh In On TRxADE HEALTH

An institutional investor recently bought a new position in TRxADE HEALTH stock. Virtu Financial LLC bought a new stake in TRxADE HEALTH, Inc. (NASDAQ:MEDS) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 10,617 shares of the company’s stock, valued at approximately $109,000. Virtu Financial LLC owned about 0.75% of TRxADE HEALTH at the end of the most recent quarter. 5.68% of the stock is currently owned by hedge funds and other institutional investors.

About TRxADE HEALTH

TRxADE HEALTH, Inc operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace.